Updating Cost Effectiveness Analyses in Orthopedic Surgery: Resilience of the $50,000 per QALY Threshold

Journal of Arthroplasty

Volumn 30, Issue 7, 2015, Pages 1118-1120

  Nwachukwu, Benedict U ^a   Bozic, Kevin J ^b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cost effectiveness; Health services; QALY; Willingness to pay

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; ECONOMIC EVALUATION; FUNDING; GOVERNMENT REGULATION; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; MEDICAL SERVICE; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; UNITED STATES; COST BENEFIT ANALYSIS; ECONOMIC MODEL; ECONOMICS; ORTHOPEDICS; PROCEDURES; QUALITY OF LIFE;

COST-BENEFIT ANALYSIS; HEALTH POLICY; HUMANS; MODELS, ECONOMIC; ORTHOPEDIC PROCEDURES; ORTHOPEDICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 84931572532     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2015.02.017     Document Type: Article

References (15)

1. Nwachukwu BU, Hamid KS, Bozic KJ. Measuring value in orthopaedic surgery. JBJS Reviews. 2013 2013-11-19 08:00:00;1(1).
2. Lansky D., Nwachukwu B.U., Bozic K.J. Using financial incentives to improve value in orthopaedics. Clin Orthop Relat Res 2012, 470(4):1027. [Epub 2011/10/18].
3. Russell L.B., Gold M.R., Siegel J.E., et al. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996, 276(14):1172. [Epub 1996/10/09].
4. Siegel J.E., Weinstein M.C., Russell L.B., et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996, 276(16):1339. [Epub 1996/10/23].
5. Grosse S.D. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008, 8(2):165. [Epub 2008/04/01].
6. Braithwaite R.S., Meltzer D.O., King J.T., et al. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?. Med Care 2008, 46(4):349. [Epub 2008/03/26].
7. Neumann P.J., Cohen J.T., Weinstein M.C. Updating cost-effectiveness-the curious resilience of the $50,000-per-QALY threshold. N Engl J Med 2014, 371(9):796. [Epub 2014/08/28].
8. Hirth R.A., Chernew M.E., Miller E., et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000, 20(3):332. [Epub 2000/08/10].
9. Neumann P.J., Weinstein M.C. Legislating against use of cost-effectiveness information. N Engl J Med 2010, 363(16):1495. [Epub 2010/10/15].
10. Schwartz J.A., Pearson S.D. Cost consideration in the clinical guidance documents of physician specialty societies in the United States. JAMA 2013, 173(12):1091. [Epub 2013/05/08].
11. Nwachukwu B.U., Bozic K.J., Schairer W.W., et al. Current status of cost utility analyses in total joint arthroplasty: a systematic review. Clin Orthop Relat Res 2014, 30. [Epub 2014/10/01].
12. Tosteson A.N., Lurie J.D., Tosteson T.D., et al. Surgical treatment of spinal stenosis with and without degenerative spondylolisthesis: cost-effectiveness after 2 years. Ann Intern Med 2008, 149(12):845. [Epub 2008/12/17].
13. Tosteson A.N., Skinner J.S., Tosteson T.D., et al. The cost effectiveness of surgical versus nonoperative treatment for lumbar disc herniation over two years: evidence from the Spine Patient Outcomes Research Trial (SPORT). Spine (Phila Pa 1976) 2008, 33(19):2108. [Epub 2008/09/09].
14. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996, 276(15):1253. [Epub 1996/10/16].
15. Slover J.D., Tosteson A.N., Bozic K.J., et al. Impact of hospital volume on the economic value of computer navigation for total knee replacement. J Bone Joint Surg Am 2008, 90(7):1492. [Epub 2008/07/03].